Startups
TesoRx is a privately held pharmaceutical company developing a first-in-class unmodified oral testosterone for androgen deficiency. It is in the process of completing a phase two clinical study and is on track to commence dosing for phase three by early 2014.
The US market for topical, transdermal and injectible testosterone formulations alone is currently estimated at $2.1 Billion with prescriptions having grown 90% over five years. Analysts project that the entire testosterone market is expected to hit $5 billion by 2017. A safe and effective oral treatment regimen remains the main unmet need and studies suggest that it could cannibalize more than 70% of existing treatments once introduced into the market.
The US market for topical, transdermal and injectible testosterone formulations alone is currently estimated at $2.1 Billion with prescriptions having grown 90% over five years. Analysts project that the entire testosterone market is expected to hit $5 billion by 2017. A safe and effective oral treatment regimen remains the main unmet need and studies suggest that it could cannibalize more than 70% of existing treatments once introduced into the market.
Overview
Location
United States, California, Menlo Park
Employees
1-10
Total raised
$10M
Founded date
2010
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 5, 2014 | TesoRx Closes $10M in Funding | MENLO PARK, CA, Specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has closed $10M in Series B-1 funding. >> Click here for more fundi... |
| Aug 1, 2012 | Pill for low testosterone in men heads for phase 2 clinical trials | Location: Menlo Park, California. Solution/product: TesoRx Pharma is currently developing TSX-002, an oral testosterone replacement therapy for men with hypogonadism. Its delivery system is intended to provide a convenient, outpatient metho... |
| Pill for low testosterone in men heads for phase 2 clinical trials | Company name: Teso Rx Pharma. Industry: Pharmaceuticals. Location: Menlo Park, California. Solution/product: TesoRx Pharma is currently developing TSX-002, an oral testosterone replacement therapy for men with hypogonadism. Its delivery sys... |
Reviews 0
FAQ about TesoRx Pharma, LLC
When was TesoRx Pharma, LLC founded?
TesoRx Pharma, LLC was founded in 2010.
How much funding has TesoRx Pharma, LLC raised?
TesoRx Pharma, LLC has raised $10M in total across 1 funding round.
What has the press written about TesoRx Pharma, LLC?
Parsers VC has collected 4 articles mentioning TesoRx Pharma, LLC, among them “TesoRx Closes $10M in Funding” (Aug 5, 2014) and “Pill for low testosterone in men heads for phase 2 clinical trials” (Aug 1, 2012).
Is TesoRx Pharma, LLC still active?
Yes, TesoRx Pharma, LLC is active; its latest activity on Parsers VC dates from Aug 5, 2014.